The European pharmaceutical industry has been grappling with unprecedented drug shortages since 2023 due to various factors like high operating costs and cost-containment policies. Norway is the most affected market, with shortages expanding to generics and branded medicines, impacting multiple European markets.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing